ACAD Signs License Deal With Saniona for Rights to Neurology Drug

Published on 27 Nov 2024 on Zacks · via Yahoo Finance

Acadia Pharmaceuticals ACAD announced that it has signed an exclusive worldwide license agreement...

Read the rest of the article

Start tracking your investments with Statfolio

Acadia Pharmaceuticals ACAD announced that it has signed an exclusive worldwide license agreement...

Zacks · via Yahoo Finance 27 Nov 2024

We recently compiled a list of the 10 Worst-Performing Growth Stocks in 2024. In this article, we...

Insider Monkey · via Yahoo Finance 31 Oct 2024

We recently compiled the list of the 7 Best Halal Stocks To Buy Now (Debt Free). In this article,...

Insider Monkey · via Yahoo Finance 18 Jun 2024

Key Insights ACADIA Pharmaceuticals' Annual General Meeting to take place on 29th of MayTotal pay...

Simply Wall St. via Yahoo Finance 22 May 2024

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript May 8, 2024 ACADIA Pha...

Insider Monkey via Yahoo Finance 9 May 2024

Acadia Pharmaceuticals Inc. ACAD reported first-quarter 2024 earnings of 10 cents per share, beat...

Zacks via Yahoo Finance 8 May 2024

The earnings season for the drug/biotech sector is now in its final lap, with two S&P 500 compani...

Zacks via Yahoo Finance 6 May 2024

On May 2, 2024, Stephen Davis, the CEO of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), sold 11,427 s...

GuruFocus.com via Yahoo Finance 4 May 2024

Stephen Davis, CEO of Acadia Pharmaceuticals Inc. (NASDAQ:ACAD), recently sold 11,427 shares of t...

Investing.com 3 May 2024

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), a biopharmaceutical company focused on the development ...

GuruFocus.com via Yahoo Finance 10 Apr 2024